Matinas BioPharma Holdings, Inc. (MTNB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.6M | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.42M | -2.19M | -4.09M | -4.3M | -4.97M | -5.13M | -4.76M | -3.96M | -5.75M | -864.65K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -372.9% | -404.46% | -467.54% | -482.69% | - | 1188503.6% | - | - |
| Operating CF Growth % | 20.23% | 57.01% | 57.89% | 34.93% | 65.21% | 23.35% | 20.8% | -41.63% | -41.15% | -6.5% | 11.09% | 57.26% | 14.06% | -8.63% | 13.56% | -493.42% | -2.25% | 8.12% | -10.01% | 72.71% |
| Net Income | -1.92M | -1.91M | -1.53M | -5.25M | -1.66M | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M | -6.05M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M |
| Depreciation & Amortization | 74K | 423K | 331K | -98K | 128K | 247K | 240K | 241K | 240K | 240K | 238K | 234K | 229K | 225.82K | 230K | 231K | 211.53K | 205.11K | 196.04K | 182.79K |
| Stock-Based Compensation | 0 | 217K | 253K | 238K | 315K | 244K | 965K | 991K | 995K | 1.27M | 1.2M | 1.21M | 1.27M | 0 | 1.41M | 1.22M | 0 | 1.07M | 1.06M | 1.06M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 113K | -14K | -220K | 3.56M | -294K | 4.35M | 7K | -37K | 18K | 18K | 17K | 29K | 44K | 1.4M | 48K | 49K | 1.61M | 80.43K | 1.26M | 54.31K |
| Working Capital Changes | 133K | -223K | -306K | -481K | -500K | 86K | -437K | 1.42M | -1.2M | -795K | 185K | 2.4M | -119K | -2.29M | -1.2M | -703K | -600.99K | 1.38M | -1.43M | 2.63M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 397K | 235K | -86K | -116K | 187K | -254K | 111K | -235K | -41K | -320K | 230K | 89K | -102K | -39.45K | 159K | -855K | 413.63K | 276.27K | 211.54K | 28.82K |
| Cash from Investing | 0 | 15K | 320K | 0 | 0 | 500K | 9.65M | -2.94M | 2M | 2.96M | 1.08M | 6.2M | 3M | -42.01K | 5.75M | -3.79M | 2.96M | 56.67K | 242.69K | 7.65M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16K | -202K | 0 | -41.6K | -250K | -55K | -544.56K | -36.19K | -224.19K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.91% | 23.52% | 5.17% | - | -10868.47% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 15K | 320K | 0 | 0 | 0 | 7.94M | -7.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 58K | 64K | 1.62M | 1.65M | -1K | -67K | 9.19M | 53K | -1K | -1K | -1K | -4K | -4.64K | -3K | -6K | 92.92K | 8.09K | -8.32K | 180.48K |
| Debt Issued (Net) | 0 | -7K | 0 | -1K | -1K | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -4K | -4.2K | -3K | -6K | -6.53K | -6.39K | -8.32K | -8.15K |
| Equity Issued (Net) | 0 | 65K | 64K | 1.65M | 1.65M | 0 | -65K | 9.19M | 54K | 0 | 0 | 0 | 0 | -441 | 0 | 0 | 99.44K | 14.48K | -1 | 188.63K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -27K | -2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Net Change in Cash | -1.6M | -1.44M | -1.09M | -399K | -360K | -3.01M | 6.08M | 3.15M | -3.72M | -1.62M | -3.34M | 4M | -1.09M | -4.35M | 777K | -8.93M | -1.7M | -3.89M | -5.52M | 6.97M |
| Free Cash Flow | -1.6M | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.43M | -2.4M | -4.09M | -4.34M | -5.22M | -5.19M | -5.3M | -3.99M | -5.97M | -864.66K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -372.9% | -408.37% | -491.06% | -487.86% | - | 1199372.37% | - | - |
| FCF Growth % | 20.23% | 57.01% | 57.89% | 34.93% | 65.21% | 23.35% | 21.08% | -29.69% | -41.15% | -5.48% | 15.04% | 53.82% | 22.89% | -8.69% | 12.62% | -499.77% | -13.96% | 7.16% | -14.3% | 72.71% |
| FCF per Share | -0.25 | -0.28 | -0.27 | -0.40 | -0.39 | -0.72 | -0.69 | -0.62 | -1.33 | -1.05 | -1.02 | -0.55 | -0.94 | -1.00 | -1.20 | -1.20 | -1.22 | -0.92 | -1.39 | -0.21 |
| FCF Conversion (FCF/Net Income) | 0.83x | 0.79x | 0.69x | 0.39x | 1.21x | 0.42x | 0.82x | 0.54x | 0.99x | 0.86x | 0.73x | 0.36x | 0.74x | 1.18x | 0.91x | 0.87x | 0.80x | 0.59x | 0.84x | 0.18x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |